Literature DB >> 16818492

Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5.

Tom Vandebroek1, Dick Terwel, Thomas Vanhelmont, Maarten Gysemans, Chris Van Haesendonck, Yves Engelborghs, Joris Winderickx, Fred Van Leuven.   

Abstract

Phosphorylation of Tau protein and binding to microtubules is complex in neurons and was therefore studied in the less complicated model of humanized yeast. Human Tau was readily phosphorylated at pathological epitopes, but in opposite directions regulated by kinases Mds1 and Pho85, orthologues of glycogen synthase kinase-3beta and cdk5, respectively (1). We isolated recombinant Tau-4R and mutant Tau-P301L from wild type, Delta mds1 and Delta pho85 yeast strains and measured binding to Taxol-stabilized mammalian microtubules in relation to their phosphorylation patterns. Tau-4R isolated from yeast lacking mds1 was less phosphorylated and bound more to microtubules than Tau-4R isolated from wild type yeast. Paradoxically, phosphorylation of Tau-4R isolated from kinase Pho85-deficient yeast was dramatically increased resulting in very poor binding to microtubules. Dephosphorylation promoted binding to microtubules to uniform high levels, excluding other modifications. Isolated hyperphosphorylated, conformationally altered Tau-4R completely failed to bind microtubules. In parallel to Tau-4R, we expressed, isolated, and analyzed mutant Tau-P301L. Total dephosphorylated Tau-4R and Tau-P301L bound to microtubules very similarly. Surprisingly, Tau-P301L isolated from all yeast strains bound to microtubules more extensively than Tau-4R. Atomic force microscopy demonstrated, however, that the high apparent binding of Tau-P301L was due to aggregation on the microtubules, causing their deformation and bundling. Our data explain the pathological presence of granular Tau aggregates in neuronal processes in tauopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818492     DOI: 10.1074/jbc.M602792200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

Review 3.  Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.

Authors:  Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Fei Liu; Cheng-Xin Gong; Inge Grundke-Iqbal
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

Review 4.  Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells.

Authors:  Jürgen J Heinisch; Roland Brandt
Journal:  Microb Cell       Date:  2016-03-25

5.  Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.

Authors:  Joëlle Rosseels; Jeff Van den Brande; Marie Violet; Dirk Jacobs; Pierre Grognet; Juan Lopez; Isabelle Huvent; Marina Caldara; Erwin Swinnen; Anthony Papegaey; Raphaëlle Caillierez; Valerie Buée-Scherrer; Sebastiaan Engelborghs; Guy Lippens; Morvane Colin; Luc Buée; Marie-Christine Galas; Eugeen Vanmechelen; Joris Winderickx
Journal:  J Biol Chem       Date:  2014-12-24       Impact factor: 5.157

6.  Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration.

Authors:  David Muyllaert; Dick Terwel; Anna Kremer; Kristina Sennvik; Peter Borghgraef; Herman Devijver; Ilse Dewachter; Fred Van Leuven
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 7.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

8.  Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease.

Authors:  Tomasz Jaworski; Sebastian Kügler; Fred Van Leuven
Journal:  Int J Alzheimers Dis       Date:  2010-08-24

9.  Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.

Authors:  Dick Terwel; David Muyllaert; Ilse Dewachter; Peter Borghgraef; Sophie Croes; Herman Devijver; Fred Van Leuven
Journal:  Am J Pathol       Date:  2008-02-07       Impact factor: 4.307

10.  Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates.

Authors:  Melina Theoni Gyparaki; Arian Arab; Elena M Sorokina; Adriana N Santiago-Ruiz; Christopher H Bohrer; Jie Xiao; Melike Lakadamyali
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.